gdFTRD System Registry for Gastroduodenal Full-Thickness Resection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational registry that collects physician-entered data from cases where the gdFTRD System was used for endoscopic full-thickness or deep partial wall resections in the upper GI tract. Data processing is the only activity; the procedure itself is not part of the study. Automatic quality checks and warnings help ensure entries are complete and within expected ranges. No patient-reported outcomes are collected, and no statistical analysis plan is specified beyond exploratory assessments if data allow. Participating centers follow their own SOPs, with data protection and regulatory compliance maintained.

Why it matters

Who can join: the full rules

Inclusion criteria:

* All patients of legal age in whom the gdFTRD was used for treatment in the upper GI tract (stomach and duodenum) independently from the registry and
* who gave informed consent to data processing

Exclusion criteria:

* Patients aged under 18 years
* Patients in whom the colonic FTRD, diagnostic FTRD or non-device assisted EFTR was used for treatment
* Patients who did not give informed consent to data processing

Where it's running

• RKH Kliniken Ludwigsburg-Bietigheim gGmbH
  Ludwigsburg, Germany, Germany Recruiting
• Robert-Bosch-Krankenhaus
  Stuttgart, Germany, Germany Recruiting
• Universitätsklinikum Freiburg - Klinik für Innere Medizin II
  Freiburg im Breisgau, Germany, Germany Not yet recruiting

Study contacts

• Principal investigator: Andreas Wannhoff, PD Dr. med. — RKH Kliniken Ludwigsburg-Bietigheim gGmbH
• Study coordinator: Bettina Stritzke
• Email: bettina.stritzke@ovesco.com
• Phone: +49 707196528-174

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• R-5780 with PD-1 blockers for adults with advanced melanoma and other solid tumors

  This Phase 1 test will try an oral probiotic called R-5780 together with PD-1 checkpoint inhibitors to see if adults with advanced solid tumors can tolerate it safely.

  Recruiting at 2 sites Phase 1 Rise Therapeutics LLC · Denver, Colorado and 1 other locations · NCT06398418

• Multi-omics approach for early detection of colorectal cancer

  This study is testing a new way to spot colorectal cancer early by looking at blood samples from people with cancer and healthy individuals to see if certain markers can help predict the disease.

  Recruiting at 6 sites Zhejiang University · Hangzhou, Zhejiang and 5 other locations · NCT06220617

• Early home return for patients after prostate adenoma surgery

  This study is testing a new way to help patients go home sooner after prostate surgery by providing supervised care at home to see if it keeps them safe and helps them recover better.

  Recruiting GCS Ramsay Santé pour l'Enseignement et la Recherche · Saint-Jean · NCT05912764

• Proton therapy for brain tumors

  This study is testing whether proton therapy can be a better treatment option for patients with certain brain tumors by comparing it to traditional radiation methods to see if it can reduce harm to healthy tissues.

  Recruiting at 3 sites Maastricht Radiation Oncology · Maastricht, Limburg and 2 other locations · NCT04648462

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.